Source: InvestorIntel

Miraculins: Miraculins Provides Update on Strategic Review Process

February 24, 2016 (Source) - Miraculins Inc. (TSXV: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, announces today that pursuant to the strategic review process the ... Continue reading →The post Miraculins Provides Update on Strategic Review Process appeared first on InvestorIntel.

Read full article »
Annual Revenue
<$1M
Employees
6
Christian Sauvageau's photo - President & CEO of Miraculins

President & CEO

Christian Sauvageau

CEO Approval Rating

75/100

Read more